Camurus AB (CAMX.ST)
CAMX.ST on Stockholm Stock Exchange
Change (% chg)
Camurus AB is a Sweden-based research and development based pharmaceutical company with a focus on the development and commercialization of specialty medicines, providing patients suffering from serious and chronic disease, such as opioid dependence, pain, cancer, acromegaly, and neuroendocrine tumors. The Company has a... (more)
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.